Your browser doesn't support javascript.
loading
LncRNA DIRC1 is a novel prognostic biomarker and correlated with immune infiltrates in stomach adenocarcinoma.
Lin, Yuning; Zhang, Zhongying; Li, Ying; Chen, Yongquan; Su, Meiying; Zhao, Wenzhen.
Afiliação
  • Lin Y; Xiamen Key Laboratory of Biomarker Translational Medicine, Medical Laboratory of Xiamen Humanity Hospital Fujian Medical University, Xiamen, China.
  • Zhang Z; Xiamen Key Laboratory of Biomarker Translational Medicine, Medical Laboratory of Xiamen Humanity Hospital Fujian Medical University, Xiamen, China.
  • Li Y; Ultrasonography Department, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, China.
  • Chen Y; Xiamen Key Laboratory of Biomarker Translational Medicine, Medical Laboratory of Xiamen Humanity Hospital Fujian Medical University, Xiamen, China.
  • Su M; Xiamen Key Laboratory of Biomarker Translational Medicine, Medical Laboratory of Xiamen Humanity Hospital Fujian Medical University, Xiamen, China.
  • Zhao W; Xiamen Key Laboratory of Biomarker Translational Medicine, Medical Laboratory of Xiamen Humanity Hospital Fujian Medical University, Xiamen, China.
Medicine (Baltimore) ; 101(46): e31839, 2022 Nov 18.
Article em En | MEDLINE | ID: mdl-36401393

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Adenocarcinoma / RNA Longo não Codificante Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Medicine (Baltimore) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Adenocarcinoma / RNA Longo não Codificante Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Medicine (Baltimore) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China